NervGen Pharma Corp. Common stock — Institutional Ownership
Which tracked institutions hold NGEN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$2005927
Total value held
Buying
8 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | $782236 | 379726 | +379726 | NEW BUY |
| 2 | Bank Of America Corp /De/ | $383572 | 186200 | -14456 | -7.20% |
| 3 | Royal Bank Of Canada | $363000 | 176075 | +4114 | +2.39% |
| 4 | Bank Of Montreal /Can/ | $284382 | 78394 | +15494 | +24.63% |
| 5 | Sprott Inc. | $51500 | 25000 | +25000 | NEW BUY |
| 6 | Wells Fargo & Company/Mn | $45320 | 22000 | +22000 | NEW BUY |
| 7 | Goldman Sachs Group Inc | $40423 | 19623 | +19623 | NEW BUY |
| 8 | Jpmorgan Chase & Co | $28840 | 14714 | +1252 | +9.30% |
| 9 | Morgan Stanley | $26654 | 12939 | +957 | +7.99% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.